GAMBINI, DAISY
 Distribuzione geografica
Continente #
NA - Nord America 77
EU - Europa 72
AS - Asia 53
AF - Africa 12
SA - Sud America 5
Totale 219
Nazione #
US - Stati Uniti d'America 75
HK - Hong Kong 22
IT - Italia 22
RU - Federazione Russa 22
SG - Singapore 14
CN - Cina 13
IE - Irlanda 10
CI - Costa d'Avorio 9
FI - Finlandia 6
BR - Brasile 5
FR - Francia 5
DE - Germania 3
MA - Marocco 3
SE - Svezia 2
BE - Belgio 1
CA - Canada 1
GB - Regno Unito 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
MX - Messico 1
TR - Turchia 1
Totale 219
Città #
Hong Kong 22
Boardman 16
Dublin 10
Moscow 10
Abidjan 9
Ancona 9
Singapore 9
Ashburn 8
Boydton 8
New York 6
Chandler 3
Guangzhou 3
Helsinki 3
Los Angeles 3
Rome 3
Turku 3
Montelupone 2
Novara 2
Nuremberg 2
San Benedetto del Tronto 2
Santa Clara 2
Shanghai 2
The Dalles 2
Washington 2
Barão de Cocais 1
Bergamo 1
Brussels 1
Canindé 1
Chicago 1
Concord 1
Contagem 1
Council Bluffs 1
Emet 1
Falconara Marittima 1
Garanhuns 1
Hengyang 1
Jining 1
Kilburn 1
Munich 1
Nasiriyah 1
Rezh 1
Seoul 1
Tokyo 1
Toronto 1
Wuxi 1
Totale 162
Nome #
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 53
Bullous Pemphygoid and Novel Therapeutic Approaches 47
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 38
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi 33
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 31
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience 28
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review 9
Totale 239
Categoria #
all - tutte 1.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202335 0 0 0 1 2 7 0 0 8 1 5 11
2023/202475 7 2 15 12 10 13 3 0 0 3 2 8
2024/2025129 19 9 5 1 9 13 17 4 21 9 22 0
Totale 239